Burkholderia cenocepacia is an opportunistic pathogen that infects cystic fibrosis patients, causing pneumonia and septicemia. B. cenocepacia has intrinsic antibiotic resistance against monobactams, aminoglycosides, chloramphenicol and fluoroquinolones that is contributed by a homologue of BpeB, which is a member of the resistance-nodulation-cell division (RND)-type multidrug-efflux transporters. Here, the cloning, overexpression, purification, construct design for crystallization and preliminary X-ray diffraction analysis of this BpeB homologue from B. cenocepacia are reported. Two truncation variants were designed to remove possible disordered regions based on comparative sequence and structural analysis to salvage the wild-type protein, which failed to crystallize. The 17-residue carboxyl-terminal truncation yielded crystals that diffracted to 3.6 Å resolution. The efflux function measured using minimal inhibitory concentration assays indicated that the truncation decreased, but did not eliminate, the efflux activity of the transporter.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213979PMC
http://dx.doi.org/10.1107/S2053230X18013547DOI Listing

Publication Analysis

Top Keywords

resistance-nodulation-cell division
8
burkholderia cenocepacia
8
construct design
8
design crystallization
8
crystallization preliminary
8
structural analysis
8
bpeb major
4
major resistance-nodulation-cell
4
division transporter
4
transporter burkholderia
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!